Skip to content
    SNDL
    Earnings call· Jun 2026(Q2 FY26)

    SNDL Q2 FY26 earnings call SNDL

    Jul 28, 2026 Source

    Executive summary

    SNDL Q2 FY26 — Strategic Restructuring and Share Repurchases Amidst Market Headwinds

    SNDL navigated a challenging Q2 FY26 marked by market headwinds in both liquor and cannabis, leading to revenue and gross profit declines. Despite these pressures, the company demonstrated financial discipline through accelerated share repurchases and maintained a strong cash position. A significant milestone was achieved with the Parallel restructuring, opening direct access to the US medical cannabis market and providing a platform for future growth and strategic optionality.

    Highlights

    5

    • Repurchased 11.7 million common shares for $23.3 million (US$1.43/share) in Q2 FY26, contributing to a 7% reduction in shares outstanding since Q4 FY24.

    • Maintained a strong balance sheet with $183.2 million of unrestricted cash and no outstanding debt as of June 30, 2026.

    • Completed the Parallel restructuring, providing direct exposure to US medical cannabis operations with expected near-term annualized revenue of approximately $150 million.

    • Improved free cash flow to negative $6.7 million, a $1.2 million year-over-year improvement despite seasonal payments.

    • Implemented profit enhancement initiatives expected to drive more than $20 million of incremental operating income.

    Concerns

    5

    • Net revenue declined 3.7% year-over-year to $235.8 million due to persistent demand softness and broader market headwinds.

    • Gross profit declined 16.6% year-over-year to $56.3 million, with gross margin down 3.7 percentage points to 23.9%.

    • Cannabis operations gross margin declined 24 percentage points to 1.8%, primarily due to significant inefficiencies from the Jitter production ramp-up.

    • Liquor retail net revenue declined 5.1% year-over-year to $134.7 million, driven by persistent market demand softness and a 6.2% decline in same-store sales.

    • Adjusted operating loss was $7 million, a $12.8 million year-over-year decline.

    Guidance & targets

    7
    CategoryTargetConfidence
    Incremental operating income from profit enhancement initiatives
    more than $20 million
    medium materiality
    High
    Parallel annualized revenue
    approximately $150 million
    high materiality
    High
    Parallel annual revenue potential
    exceed $1 billion Canadian
    high materiality
    Medium
    Jitter production ramp-up cost headwinds
    persist
    medium materiality
    High
    Free cash flow
    positive
    high materiality
    High
    Cannabis retail market growth (Alberta and Ontario)
    low single digits
    medium materiality
    Medium
    Liquor retail margins
    flat or going back to growth
    medium materiality
    Medium

    Segment performance

    6
    SegmentRevenueYoYQoQMargin
    Consolidated
    Net revenue declined due to persistent demand softness and broader market headwinds across both liquor and cannabis segments.
    		$235.8 million-3.7%——
    Liquor Retail
    Decline driven by persistent softness in market demand and increased promotional activity. Partially offset by two new YNAB Yonah stores and strong private label sales.
    Net revenue decline: $7.2 millionSame-store sales: -6.2%Private label sales: outperformed national brands by 13 percentage pointsGross profit: $33.8 millionGross profit growth YoY: -7.4%Gross margin: 25.1%Gross margin change: -60 basis pointsAdjusted Operating Income change YoY: -$3.5 million
    		$134.7 million-5.1%—$3.2 million (Adjusted Operating Income)
    Cannabis Retail
    Decline driven by market contraction in Alberta and Ontario, partially offset by new store openings and value-backed store conversions. Margin expansion supported by promotional efficiencies, pricing actions, and product mix management.
    Net revenue decline: $1.2 millionNegative same-store sales: -4.6%Gross profit: $22 millionGross profit change YoY: +$0.1 millionGross margin: 26.4%Gross margin change: +50 basis pointsAdjusted Operating Income change YoY: -$1.2 million
    		$83.2 million-1.4%—$3 million (Adjusted Operating Income)
    Cannabis Operations
    Decline driven by market headwinds and absence of B2B flower deliveries. Gross margin significantly impacted by inefficiencies from Jitter production ramp-up.
    Net revenue decline: $3.6 millionInternational sales: $5 millionInternational sales growth: +$1.2 millionGross profit: $0.6 millionGross profit change YoY: -$8.7 millionGross margin: 1.8%Gross margin change: -24 percentage pointsAdjusted Operating Loss change YoY: -$6.2 million (from -$2.8 million to -$9 million)
    		$32.2 million-10.1%—-$9 million (Adjusted Operating Loss)
    Investments
    Impacted adjusted operating income due to a Sunstream valuation adjustment.
    Sunstream valuation adjustment: -$2.3 millionPortfolio carrying value: $415.2 million
    		————
    Corporate
    Improved adjusted operating income due to lower corporate overhead costs.
    Adjusted operating income improvement: $1.4 millionLower corporate overhead costs
    		————

    Operational metrics

    14
    Unrestricted cash balance
    $183.2 million
    June 30, 2026

    Maintained a strong balance sheet with no outstanding debt.

    Share repurchases (Q2 FY26)
    11.7 million shares
    Q2 FY26

    Accelerated share repurchase activity during the quarter.

    Total share repurchases (since Q4 FY24)
    more than 29 million shares
    since Q4 FY24

    Represents disciplined capital allocation at attractive prices.

    Profit enhancement initiatives
    more than $20 million
    remainder of FY26

    Expected to drive incremental operating income mostly over the remainder of the year.

    Gross profit
    $56.3 milliondown $11.3 million YoY
    Q2 FY26

    Impacted by lower net revenue and new product production ramp-up costs.

    Gross margin
    23.9%down 3.7 percentage points
    Q2 FY26

    Overall gross margin decline.

    Operating loss
    $7.8 million
    Q2 FY26

    Reported operating loss for the quarter.

    Adjusted operating loss
    $7 milliondown $12.8 million YoY
    Q2 FY26

    Year-over-year reduction in adjusted operating income.

    2025 management incentive payment
    $6.9 million
    Q2 FY26

    Primary driver for free cash flow being negative in the quarter.

    Cash in transit increase
    $2.7 million
    Q2 FY26

    Contributed to negative free cash flow in the quarter.

    Cannabis operations gross margin shortfall from Jitter ramp-up
    80-90%
    Q2 FY26

    The vast majority of the gross margin shortfall in cannabis operations was driven by the Jitter ramp-up.

    Liquor retail adjusted operating income decline
    $3.5 million
    Q2 FY26

    Decline driven by lower revenue, increased promotional support, and higher SG&A expenses.

    Cannabis retail adjusted operating income decline
    $1.2 million
    Q2 FY26

    Decline primarily due to prior year asset impairment reversals offsetting current year benefits.

    Corporate cost improvement
    $1.4 million
    Q2 FY26

    Offset some of the declines in adjusted operating income.

    Industry KPIs

    1
    MetricValueDetails
    Business development capacity deal appetiteDebt-free balance sheet

    Deals & partnerships

    1
    ParallelRestructuring of a legacy credit investment, converting a distressed credit position into significant economic exposure to US medical cannabis operations.multi-year

    Subject to satisfying remaining legal, regulatory, accounting, and NASDAQ requirements for direct control. Establishes a stronger foundation for future performance of the business.

    Risks & headwinds

    4
    Persistent market demand softnessQ2 FY26, expected to continue for liquor retail for next couple of years

    Net revenue declined 3.7% year-over-year to $235.8 million. Liquor retail same-store sales down 6.2%. Cannabis retail same-store sales down 4.6%.

    Mitigation: Discipline execution, cost optimization, profit enhancement initiatives, improved promotional discipline, operational efficiency, selective investments.

    Cannabis operations production inefficienciesExpected to persist over the coming months

    Gross margin declined 24 percentage points to 1.8%. 80-90% of the gross margin shortfall in cannabis operations was due to Jitter ramp-up.

    Mitigation: Working closely with partners to implement process improvements and increase labor efficiency.

    Increased promotional activity in Liquor RetailQ2 FY26

    Gross margin down 60 basis points to 25.1%.

    Mitigation: Not making the same level of investments in productivity in the second half of the year, expecting margins to be flat or grow.

    Sunstream valuation adjustmentQ2 FY26

    $2.3 million reduction impacting adjusted operating income.

    What to watch in Q3 FY26

    5

    Jitter production ramp-up cost headwinds

    Coming months (Q3 FY26)
    Current80-90% of cannabis operations gross margin shortfall
    TargetReduced impact, improved efficiency

    Why it matters

    Critical for cannabis operations profitability and overall gross margin recovery.

    While we're working closely with our partners to implement process improvements and increase labor efficiency, some of these cost headwinds are expected to persist over the coming months.

    Q&A highlights

    4

    Will the capital allocation strategy shift from share repurchases to US investments (M&A, CapEx) now that direct US market access is imminent?

    Zach George stated that share repurchases remain attractive due to the equity trading below intrinsic value. The company's debt-free balance sheet and access to competitive debt capital (mid-single digits from Canadian banks) provide a cost of capital advantage. They intend to invest in the US, including improving processing capabilities in Florida and exploring opportunities in Texas, which saw a 40% revenue bump from vape introduction.

    “We still have the view that our equity is trading well below its intrinsic value. And when we look at investments that are available to us across the sector, It's still an attractive use of capital to reduce our outstanding share count.”

    asked by Aaron Gray · answered by Zachary George

    2 min read6 chapters

    Detailed Narrative

    01

    Market Headwinds and Financial Performance

    SNDL faced persistent demand softness across its liquor and cannabis segments in Q2 FY26, resulting in a 3.7% year-over-year net revenue decline to $235.8 million. Gross profit decreased by 16.6% to $56.3 million, with gross margin contracting by 3.7 percentage points to 23.9%. The company reported an adjusted operating loss of $7 million, a $12.8 million year-over-year decline, primarily due to lower gross profit, production ramp-up costs in cannabis operations, and a Sunstream valuation adjustment.

    02

    Strategic Balance Sheet and Capital Allocation

    Despite market challenges🌐, SNDL maintained a robust balance sheet with $183.2 million in unrestricted cash and no outstanding debt as of June 30, 2026. The company accelerated its share repurchase program, buying back 11.7 million common shares for $23.3 million (US$1.43/share) in Q2, contributing to a 7% reduction in shares outstanding since Q4 FY24. Management views this as a disciplined capital allocation strategy, reflecting confidence in the company's intrinsic value and long-term prospects.

    03

    Parallel Restructuring and US Market Entry

    A significant strategic milestone was the completion of the Parallel restructuring. This transaction provides SNDL with direct exposure to US medical cannabis operations in Florida, Texas, and Massachusetts, encompassing 56 retail locations and three cultivation/manufacturing sites. These operations are expected to generate approximately $150 million in near-term annualized revenue and offer the potential to exceed $1 billion in annual revenue, positioning SNDL to become a leading global cannabis retailer by store count.

    04

    Cannabis Operations Challenges and Outlook

    The cannabis operations segment experienced a 10.1% net revenue decline to $32.2 million and a substantial gross margin contraction of 24 percentage points to 1.8%. This was largely attributed to significant inefficiencies from the Jitter production ramp-up, with 80-90% of the gross margin shortfall linked to this issue. Management expects these cost headwinds to persist in the coming months⏳ but believes the challenges are fixable, aiming for positive free cash flow for the full calendar year.

    05

    Liquor Retail Performance and Strategy

    Liquor retail net revenue decreased by 5.1% year-over-year to $134.7 million, driven by persistent market demand softness and a 6.2% decline in same-store sales. Gross profit for the segment was $33.8 million, down 7.4%, with margin compression due to increased promotional activity. Despite the tough global environment for liquor, the company is focusing on improving performance within its convenience banner and leveraging the growth of its Wine and Beyond banner and private label sales.

    06

    Cannabis Retail Dynamics

    Cannabis retail net revenue saw a modest 1.4% decline to $83.2 million, primarily due to market contraction in Alberta and Ontario, reflected in a 4.6% negative same-store sales. However, gross margin expanded by 50 basis points to 26.4% due to promotional efficiencies and product mix management. Management anticipates a return to low single-digit growth in the second half of the year for this segment, driven by reduced promotional intensity and market stabilization.

    AI-generated summary of the company’s earnings call. Not investment advice.